![Michael P. Cooreman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael P. Cooreman
Plus aucun poste en cours
Fortune : 159 581 $ au 31/07/2026
Profil
Michael P.
Cooreman formerly worked at Ferring Pharmaceuticals, Inc., as Vice President-Science & Medicine from 2017 to 2020, Inventiva SA, as Chief Medical Officer from 2020 to 2025, and ImmusanT, Inc., as Chief Medical Officer from 2015 to 2017.
Dr. Cooreman received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVENTIVA SA 0,02% | 01/03/2025 | 36 500 ( 0,02% ) | 159 581 $ | 31/07/2026 |
Anciens postes connus de Michael P. Cooreman
| Sociétés | Poste | Fin |
|---|---|---|
| INVENTIVA | Directeur Technique/Scientifique/R&D | 09/07/2025 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Corporate Officer/Principal | 01/01/2020 |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Formation de Michael P. Cooreman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Health Technology |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
